Objective: Considering the potential role of lymphocytes in the pathophysiology of autism spectrum disorder (ASD), we aimed to evaluate possible alterations of T cell pools in the lymphoid organs of an animal model of autism induced by valproic acid (VPA). Pregnant Swiss mice received a single intraperitoneal injection of 600 mg/kg of VPA (VPA group) or saline (control group) on day 11 of gestation. Male offspring were euthanized on postnatal day 60 for removal of thymuses, spleens, and a pool of inguinal, axillary and brachial lymph nodes. Cellularity was evaluated, and flow cytometry analysis was performed on cell suspensions incubated with the mouse antibodies anti-CD3-FITC, anti-CD4-PE, and anti-CD8-PE-Cy7. We observed that the prenatal exposure to VPA induced a reduction in the numbers of CD3+CD4+ T cells in their lymph nodes when compared to the control animals. This was specific since it was not seen in the thymus or spleen. The consistent decrease in the number of CD4+ T cells in subcutaneous lymph nodes of mice from the animal model of autism may be related to the allergic symptoms frequently observed in ASD. Further research is necessary to characterize the immunological patterns in ASD and the connection with the pathophysiology of this disorder.
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Autism spectrum disorder (ASD) is a complex developmental condition characterized by impairments in social communication and interaction and repetitive patterns of behavior and interests [1] . Although its etiology is still unknown, both genetic and environmental factors are known to play key roles in ASD pathophysiology [2] . Recently, the involvement of the immune system [3] and neuroimmune interactions have been proposed as important etiological components of ASD [2] . In fact, immunological alterations are common in ASD due to factors such as abnormal microglial growth and activation [4] , a family history of autoimmune diseases [5] , and abnormal levels of inflammatory cytokines [6] . Food allergy is also frequently present in ASD patients, with early-and late-phase reactions, promoting gastrointestinal and skin diseases and asthma [7] .
More specifically, lymphocytic abnormalities have been reported in ASD [8] , including CD4+ T cell deficiency. A case-control study involving 30 Egyptian children (22 boys and 8 girls) with classic-onset autism, revealed that CD4 + CD25 high regulatory T cells are deficient in children with ASD [9] . The authors found that the frequency of autoimmune diseases in the families of the ASD group was 53.3% higher than for the control group, pointing to a familial autoimmune background. These data corroborate with previous studies [5, 10, 11] , and indicate a significant association between the reduced number of CD4 + CD25 high regulatory T cells and both allergic manifestations and a family history of autoimmunity.
Several studies have reported abnormalities in T-lymphocytes in about 35% of ASD patients with decreased numbers of CD4+ T cells and increased numbers of CD8+ T cells [12] . Interestingly, in a double-blind study, autistic symptoms were diminished in 56% of the patients that were treated with naltrexone, an opiate antagonist [13] . This drug increased the number of T-helper inducers and reduced the number of T-cytotoxic suppressors, resulting in a normalization of the CD4/CD8 ratio.
Furthermore, T cells appear to play a key role in many behavioral and cognitive processes [14, 15] , especially the modulation of social behavior [16] . For instance, immune-deficient mice exhibit an impairment in cognition and emotional behaviors, which has been attributed specifically to CD4+ T cell status [17] . Impaired learning and memory has been reported in SCID (severe combined immunodeficiency), Rag1 −/− , and Rag2 −/− mice (which lack T cells and B cells) [18] .
Prenatal exposure to valproic acid (VPA) in rodents triggers autistic-like morphological and behavioral outcomes [19] . This model has been developed based on the fact that maternal use of VPA during pregnancy is associated with an increased risk of ASD for the offspring [20] .
Immunological alterations such as thymic atrophy [21] and increased mRNA levels of proinflammatory cytokines in the spleen (after LPS challenge) were already described in this model [22] , but data on the T cell pools in the thymus and secondary lymphoid organs are absent. Here we investigated the status of T cell subsets in primary and secondary lymphoid organs, namely the thymus, spleen, and subcutaneous lymph nodes.
For this purpose, female Swiss mice (obtained from the Federal University of Pelotas, Pelotas, Brazil) were housed in a 12-h light-dark cycle, with a controlled temperature (22 ± 1 ° C), and water and food ad libitum. When pregnancy was determined by the presence of a vaginal plug, this was considered day 0 of gestation. On day 11 of gestation, pregnant mice received a single intraperitoneal injection of 600 mg/kg of VPA (Across Organics, New Jersey, NJ, USA) (VPA group) or saline (control group). Male offspring were anesthetized with isoflurane gas and exsanguinated on postnatal day 60. The experimental groups consisted of 9 animals per group. The study was approved by the Research Ethics Committee of the Clinical Hospital of Porto Alegre (Porto Alegre, Brazil).
For the cytofluorometric studies, cells from the thymus, spleen, and subcutaneous lymph nodes (inguinal, axillary, and brachial chains) were obtained after homogenizing the tissues with a tissue grinder and counted in Neubauer chambers. Suspensions containing 10 6 cells were prepared, and incubated with fluorochrome-labeled rat anti-mouse antibodies: anti-CD3-FITC (1: 50), anti-CD4-PE (1: 50), and anti-CD8-PE-Cy7 (1: 100) (BD Biosciences, San José, CA, USA) for 20 min with 2% FBS-PBS solution for 20 min at 4 ° C. Cells were then washed and analyzed by flow cytometry using the Attune ® acoustic focusing cytometer (Applied Biosystems, CA, USA), equipped with Attune ® cytometric software v1.2.5.
Data were statistically analyzed using SPSS for Windows (SPSS Inc., Chicago, IL, USA) and graphs were plotted with GraphPad Prism software. Results were expressed as means ± standard error (SE) and statistical comparisons were performed using multiple t tests followed by the Bonferroni correction. Samples were considered statistically different when p ≤ 0.05.
Prenatal Exposure to VPA Decreases CD4+ T Lymphocytes in Subcutaneous Lymph Nodes of Offspring
We first noticed that no differences between groups were found regarding lymphoid organ weight (Table 1) .
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Moreover, no differences were observed in the immature (CD4-CD8-and CD4+CD8+) and mature (CD3+CD4+CD8-or CD3+CD4-CD8+) T cell subsets in the thymus (Table 1) . Similarly, no differences were found in spleen-derived T cell subsets (Table 1) . Interestingly, however, in the subcutaneous lymph nodes, the numbers in the CD3+CD4+ T cell subset were significantly reduced in the VPA group (Fig. 1b) , whereas the corresponding percentage was increased (Fig. 1c) . The membrane density of CD3, CD4, and CD8, as ascertained by median fluorescent intensity (MFI) on T lymphocytes did not significantly differ between the VPA and control groups (online suppl. Figure S1 ; see www. karger.com/doi/10.1159000491395 for all online suppl. material). No statistically significant differences were found when comparing control versus VPA T cell subsets in the thymus or spleen. Considering that the etiology of ASD remains unknown, the association between this disorder and immunological disturbances is becoming more evident [3] . However, to date, it has not been elucidated whether immune disorders are causative of ASD or if ASD leads to immune alterations. Recently, more attention has been given to the postnatal immune imbalance of specific immune cell subsets, including CD4+ and CD8+ T cells. A reduced number of T cells in individuals with ASD, as well as an altered CD4+/CD8+ T cell ratio was reported in 1986 [23] , and in the following years, abnormalities such as increased TNFα and decreased IL-10 production by T cells, increased production of IL-17 [6, 24] , reduction of peripheral CD4+ [8] and dysregulation of Th1/ Th2/Th17 T cell pools [25] were all described in children with ASD.
Reports of allergic manifestations among individuals with ASD are common. For instance, experience of atopic diseases in early childhood was associated with a 3.40-fold increased risk of ASD [26] . In addition, a higher frequency of atopic dermatitis, asthma, rhinitis and serum IgE have been demonstrated in children with Asperger syndrome compared to age-matched controls (87 vs. 7%) [27] .
Exposure to VPA may lead to impairments in the proliferative process of lymphocytes in vitro [28] as well as a drastic reduction in the number of these cells in the lymph nodes, spleen, and peripheral blood [29] . Furthermore, rats exposed prenatally to VPA display thymic atrophy [21] .
An important aspect to be considered is the crosstalk between the mother and the embryo. In view of the neuroimmune influence on ASD pathophysiology and the in vitro effect of VPA on lymphocytes, we conceive that the maternal blood cells might be influenced by VPA, even upon a single injection protocol. Accordingly, the maternal immune response could influence the neuroimmune system in the embryo, like a fingerprint, interfering in neurodevelopment later. This hypothesis, associated with epigenetic changes, could explain how a single intraperitoneal injection of VPA during pregnancy is capable of triggering behavioral-like autism in the offspring, with anatomic and molecular alterations in the nervous and immune systems throughout life. In this work, no difference was found between thymus weight and cellularity in mice from the VPA and control groups. The discrepancy between results can be ascribed to differences in the animal species studied and the use of animals twice old as those reported by Schneider et al. [21] .
Given the large amount of data supporting the role of immune responses in ASD, advances in deciphering the functional interplay between immune cells and ASD symptoms will likely provide vital insights into the mechanisms and potential therapy of neurodevelopmental disorders.
